Shares in psychedelic drug developer Compass Pathways are sliding today after it announced that it will slash its headcount by 30% and focus all its efforts on its treatment-resistant depression (TRD) ...

Can’t wait to check out 'The Golden Compass' without the hassle? Check out ways to watch including rental, purchase, and subscription options, all in one place. In the US, you can currently rent, buy, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.